AELIX Therapeutics

About AELIX Therapeutics

The startup develops a therapeutic vaccine utilizing a T-cell immunogen designed to elicit a robust immune response against HIV. This approach aims to provide a potential cure for HIV infection, offering patients a pathway to overcome a chronic viral disease.

What does AELIX Therapeutics do?

The startup develops a therapeutic vaccine utilizing a T-cell immunogen designed to elicit a robust immune response against HIV. This approach aims to provide a potential cure for HIV infection, offering patients a pathway to overcome a chronic viral disease.

Where is AELIX Therapeutics located?

AELIX Therapeutics is based in Barcelona, Spain.

How much funding has AELIX Therapeutics raised?

AELIX Therapeutics has raised 13210000.

Location
Barcelona, Spain
Funding
13210000
Employees
3 employees
Major Investors
CDTI

Find Investable Startups and Competitors

Search thousands of startups using natural language

AELIX Therapeutics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

The startup develops a therapeutic vaccine utilizing a T-cell immunogen designed to elicit a robust immune response against HIV. This approach aims to provide a potential cure for HIV infection, offering patients a pathway to overcome a chronic viral disease.

Funding

$

Estimated Funding

$10M+

Major Investors

CDTI

Team (<5)

No team information available.
Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.
AELIX Therapeutics - Funding: $10M+ | StartupSeeker